Literature DB >> 23817584

Medicinal nicotine nonuse: smokers' rationales for past behavior and intentions to try medicinal nicotine in a future quit attempt.

Margaret Cook-Shimanek1, Emily K Burns, Arnold H Levinson.   

Abstract

INTRODUCTION: Nicotine replacement therapy (NRT) is a proven smoking cessation treatment. Previous research has reported low rates of NRT use among quit attempters. This study analyzed population-level nonuse rates and reasons for not using NRT.
METHODS: Data were from the 2008 adult Colorado Tobacco Attitudes and Behaviors Survey (TABS), a population-based, random-digit-dialed telephone survey (n = 14,156). Primary measures were past NRT nonuse and future intentions regarding NRT use among current smokers intending to quit. Multiple logistic regression was used to identify reasons for past NRT nonuse associated with intention to use NRT in the future, adjusted for factors known to influence NRT use.
RESULTS: Nearly, 80% of 1,095 current smokers who intended to quit had never used NRT. The most common reasons for nonuse were belief that "willpower" alone is sufficient for cessation (21.5%), perceived lack of NRT effectiveness (15.6%), and cost (14.3%). Willpower was more widely reported among Hispanics than Anglos (36.9% vs. 14.7%) and nondaily versus daily smokers (30.4% vs. 12.5%). Most previous NRT nonusers reported they would use cold turkey (65.2%) in their next quit attempt; NRT was the next most common choice (15.0%). In multivariate analysis, smokers identifying cost or willpower as a reason for previous nonuse had significantly lower odds of planning to use NRT in a future quit attempt.
CONCLUSIONS: The majority of smokers have never used NRT and do not plan to use it in the future. Cost and belief in willpower alone are significant barriers to using NRT in future smoking cessation attempt.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817584      PMCID: PMC3842129          DOI: 10.1093/ntr/ntt085

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  23 in total

1.  Latinos report less use of pharmaceutical aids when trying to quit smoking.

Authors:  Arnold H Levinson; Eliseo J Pérez-Stable; Paula Espinoza; Estevan T Flores; Tim E Byers
Journal:  Am J Prev Med       Date:  2004-02       Impact factor: 5.043

2.  Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000.

Authors:  Vilma E Cokkinides; Elizabeth Ward; Ahmedin Jemal; Michael J Thun
Journal:  Am J Prev Med       Date:  2005-01       Impact factor: 5.043

3.  Characteristics of selectors of nicotine replacement therapy.

Authors:  S Shiffman; M E Di Marino; C T Sweeney
Journal:  Tob Control       Date:  2005-10       Impact factor: 7.552

4.  Stop-smoking medications: who uses them, who misuses them, and who is misinformed about them?

Authors:  Maansi A Bansal; K Michael Cummings; Andrew Hyland; Gary A Giovino
Journal:  Nicotine Tob Res       Date:  2004-12       Impact factor: 4.244

5.  An exploration of Latino smokers and the use of pharmaceutical aids.

Authors:  Arnold H Levinson; Evelinn A Borrayo; Paula Espinoza; Estevan T Flores; Eliseo J Pérez-Stable
Journal:  Am J Prev Med       Date:  2006-06-05       Impact factor: 5.043

6.  Are smokers adequately informed about the health risks of smoking and medicinal nicotine?

Authors:  K Michael Cummings; Andrew Hyland; Gary A Giovino; Janice L Hastrup; Joseph E Bauer; Maansi A Bansal
Journal:  Nicotine Tob Res       Date:  2004-12       Impact factor: 4.244

7.  Use of the nicotine skin patch by smokers in 20 communities in the United States, 1992-1993.

Authors:  K M Cummings; A Hyland; J K Ockene; N Hymowitz; M Manley
Journal:  Tob Control       Date:  1997       Impact factor: 7.552

8.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

9.  Smoking cessation with and without assistance: a population-based analysis.

Authors:  S Zhu; T Melcer; J Sun; B Rosbrook; J P Pierce
Journal:  Am J Prev Med       Date:  2000-05       Impact factor: 5.043

Review 10.  Nicotine replacement therapy for smoking cessation.

Authors:  Lindsay F Stead; Rafael Perera; Chris Bullen; David Mant; Jamie Hartmann-Boyce; Kate Cahill; Tim Lancaster
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
View more
  6 in total

1.  Perceived role of motivation and self-efficacy in smoking cessation: A secondary data analysis.

Authors:  John R Hughes; Shelly Naud
Journal:  Addict Behav       Date:  2016-05-12       Impact factor: 3.913

2.  Is nicotine replacement therapy overvalued in smoking cessation? Analysis of smokers' and quitters' communication in social media.

Authors:  Terhi Kurko; Kari Linden; Maija Kolstela; Kirsi Pietilä; Marja Airaksinen
Journal:  Health Expect       Date:  2014-10-08       Impact factor: 3.377

Review 3.  Why do smokers try to quit without medication or counselling? A qualitative study with ex-smokers.

Authors:  Andrea L Smith; Stacy M Carter; Simon Chapman; Sally M Dunlop; Becky Freeman
Journal:  BMJ Open       Date:  2015-04-30       Impact factor: 2.692

4.  Utilization of smoking cessation medication benefits among medicaid fee-for-service enrollees 1999-2008.

Authors:  Jennifer Kahende; Ann Malarcher; Lucinda England; Lei Zhang; Paul Mowery; Xin Xu; Varadan Sevilimedu; Italia Rolle
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

5.  'Very brief advice' (VBA) on smoking in family practice: a qualitative evaluation of the tobacco user's perspective.

Authors:  Sophia Papadakis; Marilena Anastasaki; Maria Papadakaki; Μaria Antonopoulou; Constantine Chliveros; Chrissi Daskalaki; Dionisis Varthalis; Sofia Triantafyllou; Irene Vasilaki; Andy McEwen; Christos Lionis
Journal:  BMC Fam Pract       Date:  2020-06-24       Impact factor: 2.497

Review 6.  An Argument for Change in Tobacco Treatment Options Guided by the ASAM Criteria for Patient Placement.

Authors:  Jill M Williams; Marc L Steinberg; Alexandra N Kenefake; Michael V Burke
Journal:  J Addict Med       Date:  2016 Sep-Oct       Impact factor: 3.702

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.